James D. Brenton

Professor James D Brenton is a clinician scientist and Senior Group Leader at the Cancer Research UK Cambridge Institute and Professor of Ovarian Cancer Medicine in the Department of Oncology, University of Cambridge. He is an Honorary Consultant in Medical Oncology at Addenbrooke's Hospital, Cambridge University Hospitals, Ovarian Cancer Domain Lead for the 100,000 Genomes Project by Genomics England, and co-founder and Clinical Advisor to Inivata Ltd, a clinical cancer genomics company. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Brenton, James D.', query time: 0.26s Refine Results
  1. 1
    ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
    Get full text
    Article
  2. 2
    ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.
    Get fulltext
    Article
  3. 3
    A metadata approach for clinical data management in translational genomics studies in breast cancer
    Get full text
    Article
  4. 4
    Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling
    Get full text
    Article
  5. 5
    High resolution melting for mutation scanning of <it>TP53 </it>exons 5–8
    Get full text
    Article
  6. 6
    The pitfalls of platform comparison: DNA copy number array technologies assessed
    Get full text
    Article
  7. 7
    Differential expression of selected histone modifier genes in human solid cancers
    Get full text
    Article
  8. 8
    Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search